Or Refractory Follicular Lymphoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-04-20
Clinical Trial Update: A Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Tazemetostat in Combination With Lenalidomide Plus Rituximab Versus Placebo in Combination With Lenalidomide Plus Rituximab in Adult Patients at Least 18 Years of Age With Relapsed/Refractory Follicular Lymphoma. [Phase 3]
A Phase 3 trial evaluating Tazemetostat in combination with Lenalidomide and Rituximab versus placebo with Lenalidomide and Rituximab in adu…